Soleimani S, Albayrak O, Somay K, Yang H, Yigit B, Ulukan B
Front Mol Biosci. 2025; 11:1521811.
PMID: 39944754
PMC: 11813787.
DOI: 10.3389/fmolb.2024.1521811.
Abubakr S, Hazem N, Sherif R, Elhawary A, Botros K
BMC Gastroenterol. 2023; 23(1):323.
PMID: 37730560
PMC: 10512633.
DOI: 10.1186/s12876-023-02932-y.
Khodabandeh Z, Rezaeian L, Edalatmanesh M, Mogheiseh A, Tanideh N, Dianatpour M
Int J Organ Transplant Med. 2023; 13(1):15-24.
PMID: 37383424
PMC: 10294033.
Li Z, Fan Q, Chen M, Dong Y, Li F, Wang M
J Pharm Anal. 2023; 13(1):39-54.
PMID: 36820075
PMC: 9937801.
DOI: 10.1016/j.jpha.2022.11.005.
Caradonna A, Patel T, Toleska M, Alabed S, Chang S
Int J Mol Sci. 2022; 23(3).
PMID: 35163117
PMC: 8835589.
DOI: 10.3390/ijms23031182.
Silencing of CD147 inhibits hepatic stellate cells activation related to suppressing aerobic glycolysis via hedgehog signaling.
Li H, Yang L, Sun Y, Zhang Y, Chai J, Liu B
Cytotechnology. 2021; 73(2):233-242.
PMID: 33927478
PMC: 8035397.
DOI: 10.1007/s10616-021-00460-9.
Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of studies.
Al-Dhamin Z, Liu L, Li D, Zhang S, Dong S, Nan Y
World J Gastroenterol. 2021; 26(47):7444-7469.
PMID: 33384547
PMC: 7754546.
DOI: 10.3748/wjg.v26.i47.7444.
Antiliver Fibrosis Screening of Active Ingredients from L. Seeds via GC-TOF-MS and UHPLC-MS/MS.
Qiao M, Yang J, Zhao Y, Zhu Y, Wang X, Wang X
Evid Based Complement Alternat Med. 2020; 2020:8321732.
PMID: 32148553
PMC: 7049821.
DOI: 10.1155/2020/8321732.
CD44 inhibits α-SMA gene expression via a novel G-actin/MRTF-mediated pathway that intersects with TGFβR/p38MAPK signaling in murine skin fibroblasts.
Wang Y, Mack J, Maytin E
J Biol Chem. 2019; 294(34):12779-12794.
PMID: 31285260
PMC: 6709637.
DOI: 10.1074/jbc.RA119.007834.
The Use of Antifibrotic Recombinant nAG Protein in a Rat Liver Fibrosis Model.
Arafah M, Al-Qattan M, Abdulmaged-Ahmed D, Al-Nafesah G, Jadu N, Bagayawa R
Biomed Res Int. 2019; 2019:9846919.
PMID: 31275996
PMC: 6582902.
DOI: 10.1155/2019/9846919.
Metabolic Changes in Different Stages of Liver Fibrosis: In vivo Hyperpolarized C MR Spectroscopy and Metabolic Imaging.
Moon C, Shin S, Heo S, Lim H, Moon M, Poilil Surendran S
Mol Imaging Biol. 2019; 21(5):842-851.
PMID: 30693432
DOI: 10.1007/s11307-019-01322-9.
New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article.
Ebrahimi H, Naderian M, Sohrabpour A
Middle East J Dig Dis. 2018; 10(3):133-148.
PMID: 30186577
PMC: 6119836.
DOI: 10.15171/mejdd.2018.103.
Evolution of proteomic biomarker for chronic liver disease: Promise into reality.
Nallagangula K, Shashidhar K, Lakshmaiah V, Muninarayana
J Circ Biomark. 2018; 7:1849454418777186.
PMID: 29854010
PMC: 5971380.
DOI: 10.1177/1849454418777186.
Pokeweed antiviral protein attenuates liver fibrosis in mice through regulating Wnt/Jnk mediated glucose metabolism.
Zhang Y, Yu X, Wang Z, Yin M, Zhao Z, Li Y
Saudi J Gastroenterol. 2018; 24(3):157-164.
PMID: 29652027
PMC: 5985634.
DOI: 10.4103/sjg.SJG_470_17.
Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression.
Nallagangula K, Nagaraj S, Venkataswamy L, Chandrappa M
Future Sci OA. 2017; 4(1):FSO250.
PMID: 29255622
PMC: 5729599.
DOI: 10.4155/fsoa-2017-0083.
Effects of telmisartan on improving leptin resistance and inhibiting hepatic fibrosis in rats with non-alcoholic fatty liver disease.
Zhang Q, Liu Y, Wang Y, Fu L, Zhang J, Wang X
Exp Ther Med. 2017; 14(3):2689-2694.
PMID: 28962213
PMC: 5609203.
DOI: 10.3892/etm.2017.4809.
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Chow M, Lee Y, Guo G
Mol Aspects Med. 2017; 56:34-44.
PMID: 28442273
PMC: 5812256.
DOI: 10.1016/j.mam.2017.04.004.